Metabolism and excretion of asoprisnil, a novel selective progesterone receptor modulator, in healthy female subjects

被引：0
|
作者：
Lee, Ronald
Grabowski, Brian
Mulford, Darcy
Castagnoli, Neal
Rottmann, Antje
Chwalisz, Kristof
机构：
[1] TAP Pharmaceut Prod Inc, DMPK, Lake Forest, IL USA
[2] Virginia Polytech Inst & State Univ, Dept Chem, Blacksburg, VA 24061 USA
[3] Schering AG, Pharmacokinet Metab & Bioanalysis, D-1000 Berlin, Germany
[4] TAP Pharmaceut Prod Inc, Womens Hlth, Lake Forest, IL USA
来源：
DRUG METABOLISM REVIEWS | 2006年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
268
引用
收藏
页码：172 / 173
页数：2
相关论文
共 50 条
  • [41] Effect of ketoconazole and rifampin on the single dose pharmacokinetics of asoprisnil and its metabolite in healthy female subjects.
    Lee, RD
    Witt, G
    Chwalisz, K
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P49 - P49
  • [42] Disposition of lasofoxifene, a next-generation selective estrogen receptor modulator, in healthy male subjects
    Prakash, Chandra
    Johnson, Kim A.
    Gardner, Mark J.
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (07) : 1218 - 1226
  • [43] Effect of erythromycin on the pharmacokinetics of asoprisnil and its active metabolite J912 in healthy female subjects.
    Lee, RD
    Zhang, W
    Vernillet, L
    Andhivarothai, N
    Chwalisz, K
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P25 - P25
  • [44] Pharmacokinetics, Metabolism and Excretion of an Adenosine A1 Receptor Antagonist, Tonapofylline, in Healthy Human Subjects
    Li, Zhaoyang
    Yang, Liyu
    Gan, Liang-Shang
    Klunk, Lewis
    Deykin, Aaron
    Chandra, Prakash
    DRUG METABOLISM REVIEWS, 2010, 42 : 95 - 96
  • [45] A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFβ3 and their receptors in cultured uterine leiomyoma cells
    Wang, Jiayin
    Ohara, Noriyuki
    Wang, Zhuo
    Chen, Wei
    Morikawa, Akira
    Sasaki, Hiroko
    DeManno, Deborah A.
    Chwalisz, Kristof
    Maruo, Takeshi
    HUMAN REPRODUCTION, 2006, 21 (07) : 1869 - 1877
  • [46] Effects of the selective estrogen receptor modulator raloxifene (RLX) on bone metabolism in healthy males.
    Uebelhart, B
    Bonjour, JP
    Draper, MW
    Pavo, I
    Basson, R
    Rizzoli, R
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S229 - S229
  • [47] The Selective Progesterone Receptor Modulator Ulipristal Acetate Inhibits the Activity of the Glucocorticoid Receptor
    Small, Benjamin
    Millard, Charles E. F.
    Kisanga, Edwina P.
    Burman, Andreanna
    Anam, Anika
    Flannery, Clare
    Al-Hendy, Ayman
    Whirledge, Shannon
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (03): : 716 - 734
  • [48] Absorption, distribution, metabolism, and excretion of radiolabeled naldemedine in healthy subjects
    Ohnishi, Shuichi
    Fukumura, Kazuya
    Kubota, Ryuji
    Wajima, Toshihiro
    XENOBIOTICA, 2019, 49 (09) : 1044 - 1053
  • [49] Selective progesterone receptor modulator asoprisnil (J867) inhibits proliferation and induces apoptosis in cultured uterine leiomyoma cells but not in cultured normal myometrial cells.
    Chen, W
    FERTILITY AND STERILITY, 2005, 84 : S152 - S152
  • [50] PHARMACOKINETICS, METABOLISM, AND EXCRETION OF GS-4997 IN HEALTHY SUBJECTS
    Nelson, C. H.
    Tarnowski, T.
    Wang, L.
    Vimal, M. M.
    Aoyama, R.
    O'Riordan, T.
    Xin, Y.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S80 - S80
12345